HOMEMaxvetNewBendan (Pimobendan)
犬心奔騰外盒A.png
NewBendan (Pimobendan)
Composition
Each NewBendan tablet, contains 5mg of Pimobendan
Indication
Canine Indications: Indicated for the treatment of congestive heart failure resulting from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation). For detailed application and dosage instructions, please refer to the package leaflet under "Application and Dosage." Additionally, it is used in Doberman Pinschers diagnosed with preclinical dilated cardiomyopathy via cardiac ultrasound, characterized by an increase in left ventricular end-systolic and end-diastolic diameters without clinical signs or symptoms.
Features

NewBendan (Pimobendan) is a highly effective treatment for congestive heart failure in small animals caused by dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation). It enhances cardiac output and promotes vasodilation, improving overall cardiovascular function. Extensive clinical studies and authoritative reports have demonstrated its significant therapeutic efficacy, making it a trusted choice for managing heart failure in veterinary medicine.

NB-1.png

NB-2.png